Clinical Trials in Salt Lake City

Showing 8621-8640 of 16,694 trials

Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age

NCT01310413

This study will assess safety and immunogenicity of GSK Biologicals' H5N1 flu candidate vaccine GSK1557484A in children 6 months to \< 18 years of age.

InfluenzaInfluenza Vaccines

GlaxoSmithKline842 participantsStarted Mar 2011

Paramount, California, United States • Sacramento, California, United States • Newton, Kansas, United States +14 more locations

COMPLETEDPhase 3371 miles

A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides

NCT00001028

To compare the safety and efficacy of aerosolized pentamidine and dapsone in the prevention of Pneumocystis carinii pneumonia (PCP) in high-risk HIV-infected patients who are intolerant to trimethoprim and/or sulfonamides. Both aerosolized pentamidine and dapsone have been shown to prevent PCP, but both drugs cause side effects. This study attempts to determine which drug is more efficacious as prophylaxis against PCP in patients who cannot tolerate trimethoprim/sulfamethoxazole.

Pneumonia, Pneumocystis CariniiHIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)400 participants

San Francisco, California, United States • Denver, Colorado, United States • Wilmington, Delaware, United States +11 more locations

Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age

A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides

Find Trials by Condition in Salt Lake City

Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients

Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS

Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy

Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV

A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV

A Study of HIV-Disease Development in Aging

Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV

Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants

Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat

Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia (BMT CTN 0303)

A Study of Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS Related Complex (ARC)

Effect of an Intrauterine Contraceptive Device (IUD) in HIV Infected Women

A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia

Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis

Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection

An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age